Break down carbapenem-resistant Enterobacterales

By GenePOC

Carbapenem-resistant Enterobacterales are a major global health risk, as they are becoming increasingly immune to a wide variety of antibiotics. We talk to Dr Axel Hamprecht, from the Institute for Medical Microbiology, Immunology and Hygiene at Cologne University Hospital, about combating the problem with GenePOC and their innovative revogene system.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.